Alzheimer's Disease
Understanding Biomarkers, Big Data, and Therapy
Nearly 44 million people have Alzheimer's or related dementia worldwide, according to the Alzheimer's Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia. First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and th…
Mehr
CHF 249.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
- ISBN: 978-0-12-821334-6
- EAN: 9780128213346
- Produktnummer: 35826207
- Verlag: Elsevier Science Publishing Co Inc
- Sprache: Englisch
- Erscheinungsjahr: 2021
- Seitenangabe: 254 S.
- Masse: H22.9 cm x B15.2 cm x D0.0 cm 450 g
- Gewicht: 450
- Sonstiges: Professional & Vocational
Über den Autor
Dr. Ahmed A. Moustafa is an associate professor in Cognitive and Behavioral Neuroscience at the Marcs Institute for Brain, Behavior, and Development, and in the School of Social Sciences and Psychology, Western Sydney University. He is trained in computer science, psychology, neuroscience, and cognitive science. His early training took place at Cairo University in mathematics and computer science. Before joining Western Sydney University as a lab director, he spent 11 years in America studying psychology and neuroscience. Heresearches computational and neuropsychological studies of addiction, schizophrenia, Parkinson's disease, PTSD, and depression. He has published more than 150 papers in high-ranking journals including Science, PNAS, Journal of Neuroscience, Brain, Neuroscience and Biobehavioral Reviews, and Neuron.
17 weitere Werke von Ahmed A. Moustafa:
Bewertungen
Anmelden